Qualit-E-SpeakPharma-Insert
X

Find drug development pipeline and deal Updates information

A collaboration with SCORR Marketing

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Recombinant coagulation factor IX

            Therapeutic Area: Genetic Disease

            Highest Development Status: Approved Product Type: Large molecule

            Partner/Sponsor/Collaborator: Medexus Pharmaceuticals

            Deal Size: $30.0 million Upfront Cash: $30.0 million

            Deal Type: Acquisition February 28, 2020

            Details:

            Acquisition strengthens Medexus’ specialty product portfolio and represents a strategic fit with other products in the Medexus business development pipeline.